At a glance
ClinicalIndex Comparison RecordN/ACompleted· 20 enrolled
Drug / intervention
Coffee +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Effects of Caffeine on Human Spinal Motoneurons
In Brief
A clinical study evaluating Coffee and Decaffeinated coffee for Healthy. Completed, enrolled 20 participants across 1 site.
Detailed Summary
This study evaluates the effects of orally ingested, commercially available, coffee (3 mg/kg of caffeine) on the excitability of human spinal motoneurons of the lower leg.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20222023202420252026
First PostedMay 2021
Enrollment StartJun 2021
Primary CompletionMar 2022
TodayJul 2026
First PostedMay 18, 2021
Enrollment StartJun 1, 2021
Primary CompletionMar 28, 2022
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 5.1 years ago
Interventions
Coffeedietary
Starbucks brand "Via" instant coffee. (Caffeine Content: 3 mg / kg)
Decaffeinated coffeedietary
Starbucks brand "Via" instant decaffeinated coffee. (Caffeine Content: 15 - 25 mg)